Stock listing

Biogen Inc.

Selected listing: 789617 · LS · EUR · DE

Biogen Inc. (Lang & Schwarz: 789617), Health Technology. Latest release Oct 2, 2026: Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New…

789617:LSEURDEUpdated September 25, 2026
Biogen Inc. logo
Ticker
Lang & Schwarz: 789617
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Lang & Schwarz
Currency
EUR

About Biogen Inc.

The company focuses on developing therapies for neurological diseases and has a strong portfolio of innovative treatments. Biogen is committed to advancing scientific research and improving patient outcomes in the field of neuroscience.

Latest news from Biogen Inc.

All Biogen Inc. news →

Events

Replays

  • Biogen Inc. (BIIB) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 08:30 AM ET

    Watch
  • Biogen Inc. (BIIB) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 08:00 AM ET

    Watch
  • Biogen Inc. (BIIB) Q4 2025 Earnings Call

    Fri, Feb 06, 2026 · 08:30 AM ET

    Watch

Research Biogen Inc.

Alternate listings